Bridgeway Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $889K | Hold |
|
|||||
|
2017
Q3 | $982K | Sell |
|
|||||
|
2017
Q2 | $985K | Buy |
|
|||||
|
2017
Q1 | $572K | Buy |
|
|||||
|
2016
Q4 | $75K | Sell |
|
|||||
|
2016
Q3 | $172K | Buy |
|
|||||
|
2016
Q2 | $90K | Hold |
|
|||||
|
2016
Q1 | $122K | Sell |
|
|||||
|
2015
Q4 | $960K | Hold |
|
|||||
|
2015
Q3 | $1.19M | Sell |
|
|||||
|
2015
Q2 | $1.93M | Hold |
|
|||||
|
2015
Q1 | $842K | Hold |
|
|||||
|
2014
Q4 | $982K | Buy |
|
|||||
|
2014
Q3 | $447K | Buy |
|
|||||
|
2014
Q2 | $739K | Hold |
|
|||||
|
2014
Q1 | $682K | Hold |
|
|||||
|
2013
Q4 | $401K | Hold |
|
|||||
|
2013
Q3 | $470K | Hold |
|
|||||
|
2013
Q2 | $358K | Buy |
|